7 results match your criteria: "Institute for Pathology and Toxicology[Affiliation]"
Arch Toxicol
July 2006
Institute for Pathology and Toxicology, ALTANA Pharma AG, Friedrich-Ebert-Damm 101, 22047, Hamburg, Germany.
Teratogenic effects caused by a new nitroimidazopyridazine were examined in Wistar (WU) rats after repeated oral administration of 0, 2.5, 10, and 40 mg/kg, given on days 6-17 post coitum (p.c.
View Article and Find Full Text PDFFundam Clin Pharmacol
April 2002
Institute for Pathology and Toxicology at Byk Gulden, Altana Pharma, Hamburg, Germany.
In the ILSI Human Toxicity Program, human toxicity was identified with 94% in studies of 1 month or less duration. Safety pharmacology studies and 1 month toxicity studies are prerequisites of INDs. These studies contributed in 69% to the predictivity of human toxicity.
View Article and Find Full Text PDFIARC Sci Publ
October 1994
Byk Gulden Pharmaceuticals, Institute for Pathology and Toxicology, Hamburg, Germany.
J Exp Anim Sci
April 1993
Institute for Pathology and Toxicology, Byk Gulden Pharmaceuticals, Germany.
The preputial and clitoral glands of 111-114-week-old B6C3F1-mice from a carcinogenesis experiment showed histomorphological characteristics. The lesions were considered to be spontaneous age changes, because the type, incidence and severity do not distinguish treated animals from controls. The most common findings were atrophy of the acini, lymphocytic infiltrates and hyperplasia of the squamous cell epithelium.
View Article and Find Full Text PDFExp Toxicol Pathol
August 1992
Institute for Pathology and Toxicology BYK Gulden, Hamburg, Germany.
The purpose of the present study was the evaluation of ultrastructural characteristics of the enterochromaffin-like (ECL) cells in the fundic mucosa of three different rat strains without treatment and after treatment with the H+, K(+)-ATPase inhibitor pantoprazole. In the study, 20 one year old female Sprague Dawley (SD), Fischer 344 (F) and Wistar (W) rats each were treated orally for three months with 4 mg pantoprazole/kg/d or with the vehicle only. The control animals showed close conformity of ECL cell density and morphology in all three strains.
View Article and Find Full Text PDFPathol Res Pract
June 1992
Byk Gulden Pharmaceuticals, Institute for Pathology and Toxicology, Hamburg, FRG.
Three different rat strains, Sprague-Dawley, Wistar and Fischer 344, were treated for 3 months with 2 doses (0.8; 4 mg/kg) of the gastric acid suppressing ATPase inhibitor pantoprazole. The gastrin levels were determined, the height of the mucosa measured and the number of enterochromaffin-like (ECL) cells counted.
View Article and Find Full Text PDFJ Cancer Res Clin Oncol
April 1991
Institute for Pathology and Toxicology, BYK Gulden Pharmaceuticals, Hamburg, Federal Republic of Germany.
The aim of this study was to produce large liver tumors reliably, and to diagnose the tumors during development. Therefore, New Zealand white rabbits were treated with N-nitrosodiethylamine orally three times per week by gavage and were examined by clinical-chemical assay at regular intervals during the average treatment period of 14 months. The total cumulative dose was 1200 mg N-nitrosodiethylamine over 14 months.
View Article and Find Full Text PDF